Otto Warburg's contributions to current concepts of cancer metabolism
The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
Otto Warburg pioneered quantitative investigations of cancer cell metabolism, as well as photosynthesis and respiration. Warburg and co-workers showed in the 1920s that, under aerobic conditions, tumour tissues metabolize approximately tenfold more glucose to lactate in a given time than normal tissues, a phenomenon known as the Warburg effect. However, this increase in aerobic glycolysis in cancer cells is often erroneously thought to occur instead of mitochondrial respiration and has been misinterpreted as evidence for damage to respiration instead of damage to the regulation of glycolysis. In fact, many cancers exhibit the Warburg effect while retaining mitochondrial respiration. We re-examine Warburg's observations in relation to the current concepts of cancer metabolism as being intimately linked to alterations of mitochondrial DNA, oncogenes and tumour suppressors, and thus readily exploitable for cancer therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under hypoxic conditions, central tumor cells rely heavily on anaerobic metabolism, resulting in the accumulation of lactic acid and carbonic acid, which collectively reduce the extracellular pH [107,108].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [107]
In the citing paper
“pH measurements within spheroid cores consistently range between 6.5 and 7.2, which closely mirrors the acidic pH observed in solid tumors [107,113].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [107]
In the citing paper
“In contrast to tumour cells, which typically preferentially use glycolysis in the presence of oxygen to generate energy”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [40]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · cited 1×
“However, with the discoveries of oncogenic mutations in mitochondrial metabolic enzymes, such as fumarate hydratase (FH), succinate dehydrogenase (SDH) and isocitrate dehydrogenase 2 (IDH2), it is now untenable to deny the role of metabolism in tumorigenesi”
BackgroundRegulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416 · cited 1×
“in 1925 to be very much lower than the levels observed in the in vitro experiments of Warburg and co-worker”
BackgroundCancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875 · cited 1×
“Thus, tumorigenesis is enhanced through the modification of the epigenom”
BackgroundThe M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“Pyruvate kinase M2 (PKM2), which converts phosphoenolpyruvate to pyruvate, favours aerobic glycolysis in cellular transformation compared with PKM1, which is encoded by alternative splicing of the PK mRN”
BackgroundTumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804 · cited 1×
“Mitochondrial defects and the Warburg effect Over the past two decades, the discoveries of oncogenes and tumour suppressor genes have created a paradigm in which cell-autonomous genetic alterations were perceived as the sole driving force for neoplastic transformatio”
Background
Research works printed but not linked: 10
- Werner, P. Ein Genie irrt seltener. Otto Heinrich Warburg. Ein Lebensbild in Dokumenten (Akademie Verlag, Berlin, 1991).
- Krebs, H. Otto Warburg, Zellphysiologe, Biochemiker, Mediziner (Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 1979).
- Werner, P. Otto Warburg. Von der Zellphysiologie zur Krebsforschung (Verlag Neues Leben, Berlin, 1988).
- Koepcke, C. Lotte Warburg (Iudicium, München, 2000).
- Warburg, O. Versuche an überlebendem Carcinom-Gewebe (Methoden). Biochem. Zeitschr. 142, 317–333 (1923).
- Warburg, O. Verbesserte Methode zur Messung der Atmung und Glykolyse. Biochem. Zeitschr. 152, 51–63 (1924).
- Warburg, O., Posener, K. & Negelein, E. Über den Stoffwechsel der Carcinomzelle. Biochem. Zeitschr. 152, 309–344 (1924). In this landmark paper, Warburg and co-workers reported quantitative descriptions of respiration and lactic acid production measured by manometry in a variety of normal, embryonic and cancerous tissues.
- Warburg, O. & Hiepler, E. Versuche mit Ascites-Tumorzellen. Z. Naturforsch. 7b, 193–194 (1952).
- Warburg, O. in New Methods of Cell Physiology Applied to Cancer, Photosynthesis, and Mechanism of X-Ray Action. Developed 1945–1961 (ed. Warburg, O.) 631–632 (Interscience Publishers, New York, 1962). This book contains reprints of Warburg's work on both cancer cell metabolism and photosynthesis published from 1945–1961. Most contributions are in German, but some are in English, including a three-part forum “On respiratory impairment in cancer cells” that appeared in Science in 1956. In the penultimate chapter of the book, Warburg revises his classification of cancer cells as cells in which respiration is insufficient rather than impaired.
- Warburg, O. Über Milchsäurebildung beim Wachstum. Biochem. Zeitschr. 160, 307–311 (1925).
Cited by
Items 101–200 of 1,013
Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment
Pérez-Tomás, R., & Pérez-Guillén, I. (2020) · Cancers · doi:10.3390/cancers12113244 · Cited by 385
Calcium Channels and Pumps in Cancer: Changes and Consequences
Monteith, G. R., Davis, F. M., & Roberts-Thomson, S. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.343061 · Cited by 388
Glucose transporters in cancer metabolism
Adekola, K., Rosen, S. T., & Shanmugam, M. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328356da72 · Cited by 382
“One of the earliest reports of a possible role for glucose metabolism in cancer proliferation was described by Otto Warburg in the early 1900s [5].”
BackgroundActivity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
Polański, R., Hodgkinson, C. L., Fusi, A., Nonaka, D., Priest, L., Kelly, P., Trapani, F., Bishop, P. W., White, A., Critchlow, S. E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2270 · Cited by 378
Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo
De Feyter, H. M., Behar, K. L., Corbin, Z. A., Fulbright, R. K., Brown, P. B., McIntyre, S., Nixon, T. W., Rothman, D. L., & de Graaf, R. A. (2018) · Science Advances · doi:10.1126/sciadv.aat7314 · Cited by 376
“This meta bolic phenotype was first described by Otto Warburg and is well known in cancer biology (18, 19).”
MethodHIFs, angiogenesis, and metabolism: Elusive enemies in breast cancer
de Heer, E. C., Jalving, M., & Harris, A. L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137552 · Cited by 372
Fueling thought: Management of glycolysis and oxidative phosphorylation in neuronal metabolism
Yellen, G. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201803152 · Cited by 371
How does Lin28 let-7 control development and disease?
Thornton, J. E., & Gregory, R. I. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.06.001 · Cited by 369
The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics
Panigrahi, D. P., Praharaj, P. P., Bhol, C. S., Mahapatra, K. K., Patra, S., Behera, B. P., Mishra, S. R., & Bhutia, S. K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.015 · Cited by 362
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Zheng, P., Zhou, C., Lu, L., Liu, B., & Ding, Y. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02485-0 · Cited by 352
“Background In the past, aerobic glycolysis was thought to be the primary energy source for cancer cells because many cancers showed enhanced glycolysis even when oxygen was abundant [1].”
BackgroundMitochondrial VDAC1: A Key Gatekeeper as Potential Therapeutic Target
Camara, A. K. S., Zhou, Y., Wen, P.-C., Tajkhorshid, E., & Kwok, W.-M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00460 · Cited by 352
Modulation of inflammation by autophagy: Consequences for human disease
Netea-Maier, R. T., Plantinga, T. S., van de Veerdonk, F. L., Smit, J. W., & Netea, M. G. (2016) · Autophagy · doi:10.1080/15548627.2015.1071759 · Cited by 349
Zhao, D., Zou, S.-W., Liu, Y., Zhou, X., Mo, Y., Wang, P., Xu, Y.-H., Dong, B., Xiong, Y., Lei, Q.-Y., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.005 · Cited by 345
Mitochondrial copper depletion suppresses triple-negative breast cancer in mice
Cui, L., Gouw, A. M., LaGory, E. L., Guo, S., Attarwala, N., Tang, Y., Qi, J., Chen, Y.-S., Gao, Z., Casey, K. M., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-0707-9 · Cited by 343
Metabolism of [U‐ 13 C]glucose in human brain tumors in vivo
Maher, E. A., Marin‐Valencia, I., Bachoo, R. M., Mashimo, T., Raisanen, J., Hatanpaa, K. J., Jindal, A., Jeffrey, F. M., Choi, C., Madden, C., et al. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2794 · Cited by 341
“The data reinforce a recent re-examination of Warburg’s work that stressed the complexity of tumor metabolism and the lack of evidence for the suppression of respiration in most tumors, even those studied in Warburg’s early experiments (39).”
ResultMetabolic Codependencies in the Tumor Microenvironment
Dey, P., Kimmelman, A. C., & DePinho, R. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1211 · Cited by 328
Mitophagy defects arising from BNip3 loss promote mammary tumor progression to metastasis
Chourasia, A. H., Tracy, K., Frankenberger, C., Boland, M. L., Sharifi, M. N., Drake, L. E., Sachleben, J. R., Asara, J. M., Locasale, J. W., Karczmar, G. S., et al. (2015) · EMBO reports · doi:10.15252/embr.201540759 · Cited by 331
Chen, J.-Q., & Russo, J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.06.004 · Cited by 327
Comparative Metabolic Flux Profiling of Melanoma Cell Lines
Scott, D. A., Richardson, A. D., Filipp, F. V., Knutzen, C. A., Chiang, G. G., Ronai, Z. A., Osterman, A. L., & Smith, J. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.282046 · Cited by 328
Yang, L., Moss, T., Mangala, L. S., Marini, J., Zhao, H., Wahlig, S., Armaiz‐Pena, G., Jiang, D., Achreja, A., Win, J., et al. (2014) · Molecular Systems Biology · doi:10.1002/msb.20134892 · Cited by 326
“…we uncover Gln’s differential modulation of cancer cell hallmarks including deregulated cellular energetics (Dang, 2010; Hanahan & Weinberg, 2011; Koppenol et al, 2011), reductive carboxylation for biosynthesis (Metallo et al, 2012; Mullen et al, 2012) and shifts in energy metabolism (Vander…”
BackgroundTargeting SREBP-1-driven Lipid Metabolism to Treat Cancer
Guo, D., Bell, E., Mischel, P., & Chakravarti, A. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990486 · Cited by 323
Metabolic origins of spatial organization in the tumor microenvironment
Carmona-Fontaine, C., Deforet, M., Akkari, L., Thompson, C. B., Joyce, J. A., & Xavier, J. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700600114 · Cited by 323
Tan, Z., Xie, N., Cui, H., Moellering, D. R., Abraham, E., Thannickal, V. J., & Liu, G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402469 · Cited by 322
Mitochondria and cancer chemoresistance
Guerra, F., Arbini, A. A., & Moro, L. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.012 · Cited by 323
Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects
Chen, A.-N., Luo, Y., Yang, Y.-H., Fu, J.-T., Geng, X.-M., Shi, J.-P., & Yang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688910 · Cited by 324
T cell metabolic fitness in antitumor immunity
Siska, P. J., & Rathmell, J. C. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.007 · Cited by 312
Shestov, A. A., Liu, X., Ser, Z., Cluntun, A. A., Hung, Y. P., Huang, L., Kim, D., Le, A., Yellen, G., Albeck, J. G., et al. (2014) · eLife · doi:10.7554/elife.03342 · Cited by 315
Tan, Y., Li, J., Zhao, G., Huang, K.-C., Cardenas, H., Wang, Y., Matei, D., & Cheng, J.-X. (2022) · Nature Communications · doi:10.1038/s41467-022-32101-w · Cited by 306
New aspects of the Warburg effect in cancer cell biology
Bensinger, S. J., & Christofk, H. R. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.02.003 · Cited by 307
Bajzikova, M., Kovarova, J., Coelho, A. R., Boukalova, S., Oh, S., Rohlenova, K., Svec, D., Hubackova, S., Endaya, B., Judasova, K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.10.014 · Cited by 306
“While increased mitochondrial contribution to total ATP production was concurrent with OXPHOS reconstitution, ATP synthase assembly and appearance of tumors, the total ATP content in the cells and energy charge were not, in general, significantly decreased, but maintained by glycolysis with its much faster kinetics co…”
BackgroundCollateral sensitivity as a strategy against cancer multidrug resistance
Pluchino, K. M., Hall, M. D., Goldsborough, A. S., Callaghan, R., & Gottesman, M. M. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.03.002 · Cited by 305
“Additionally, cancer cells have historically been thought to rely primarily on glycolysis to meet energy needs, and have diminished rates of oxidative phosphorylation (the Warburg effect) (Cairns et al., 2011; Koppenol et al., 2011).”
BackgroundMitochondrial ROS control of cancer
Idelchik, M. D. P. S., Begley, U., Begley, T. J., & Melendez, J. A. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.005 · Cited by 303
The Warburg Effect 97 Years after Its Discovery
Pascale, R. M., Calvisi, D. F., Simile, M. M., Feo, C. F., & Feo, F. (2020) · Cancers · doi:10.3390/cancers12102819 · Cited by 300
Davis, R. T., Blake, K., Ma, D., Gabra, M. B. I., Hernandez, G. A., Phung, A. T., Yang, Y., Maurer, D., Lefebvre, A. E. Y. T., Alshetaiwi, H., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0477-0 · Cited by 300
Metabolic Pathway Alterations that Support Cell Proliferation
Vander Heiden, M. G., Lunt, S. Y., Dayton, T. L., Fiske, B. P., Israelsen, W. J., Mattaini, K. R., Vokes, N. I., Stephanopoulos, G., Cantley, L. C., Metallo, C. M., et al. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2012.76.010900 · Cited by 301
“Nevertheless, it has also been argued that increased glycolysis in cancer may allow ATP generation at a faster rate (Koppenol et al. 2011).”
BackgroundLost in Transition: Start-Up of Glycolysis Yields Subpopulations of Nongrowing Cells
van Heerden, J. H., Wortel, M. T., Bruggeman, F. J., Heijnen, J. J., Bollen, Y. J. M., Planqué, R., Hulshof, J., O’Toole, T. G., Wahl, S. A., & Teusink, B. (2014) · Science · doi:10.1126/science.1245114 · Cited by 296
Exercise-dependent regulation of the tumour microenvironment
Koelwyn, G. J., Quail, D. F., Zhang, X., White, R. M., & Jones, L. W. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.78 · Cited by 296
Dong, L.-F., Kovarova, J., Bajzikova, M., Bezawork-Geleta, A., Svec, D., Endaya, B., Sachaphibulkij, K., Coelho, A. R., Sebkova, N., Ruzickova, A., et al. (2017) · eLife · doi:10.7554/elife.22187 · Cited by 297
Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer
Hu, J., Hwang, S. S., Liesa, M., Gan, B., Sahin, E., Jaskelioff, M., Ding, Z., Ying, H., Boutin, A. T., Zhang, H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.028 · Cited by 296
Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY‐876
Siebeneicher, H., Cleve, A., Rehwinkel, H., Neuhaus, R., Heisler, I., Müller, T., Bauser, M., & Buchmann, B. (2016) · ChemMedChem · doi:10.1002/cmdc.201600276 · Cited by 294
Whitaker-Menezes, D., Martinez-Outschoorn, U. E., Flomenberg, N., Birbe, R., Witkiewicz, A. K., Howell, A., Pavlides, S., Tsirigos, A., Ertel, A., Pestell, R. G., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.23.18151 · Cited by 292
Pastò, A., Bellio, C., Pilotto, G., Ciminale, V., Silic-Benussi, M., Guzzo, G., Rasola, A., Frasson, C., Nardo, G., Zulato, E., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2010 · Cited by 293
“Cancer cells, unlike normal cells, privilege conversion of pyruvate to lactic acid for ATP generation rather than mitochondrial oxidative phosphorylation even in the presence of oxygen [1]: this peculiar metabolic profile is termed “aerobic glycolysis” or the “Warburg effect”.”
Autophagy and disease: always two sides to a problem
Sridhar, S., Botbol, Y., Macian, F., & Cuervo, A. M. (2012) · The Journal of Pathology · doi:10.1002/path.3025 · Cited by 293
Trépo, E., Romeo, S., Zucman-Rossi, J., & Nahon, P. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.03.011 · Cited by 291
ROS homeostasis and metabolism: a critical liaison for cancer therapy
Kim, J., Kim, J., & Bae, J.-S. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.119 · Cited by 293
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer
Fontana, F., Giannitti, G., Marchesi, S., & Limonta, P. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.89942 · Cited by 280
Metabolic reprogramming in cancer: Mechanisms and therapeutics
Nong, S., Han, X., Xiang, Y., Qian, Y., Wei, Y., Zhang, T., Tian, K., Shen, K., Yang, J., & Ma, X. (2023) · MedComm · doi:10.1002/mco2.218 · Cited by 287
Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells
Colwell, N., Larion, M., Giles, A. J., Seldomridge, A. N., Sizdahkhani, S., Gilbert, M. R., & Park, D. M. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now258 · Cited by 284
Expanding roles of superoxide dismutases in cell regulation and cancer
Che, M., Wang, R., Li, X., Wang, H.-Y., & Zheng, X. F. S. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.10.001 · Cited by 270
Hypoxia-Driven Immune Escape in the Tumor Microenvironment
Vito, A., El-Sayes, N., & Mossman, K. (2020) · Cells · doi:10.3390/cells9040992 · Cited by 270
A metabolic prosurvival role for PML in breast cancer
Carracedo, A., Weiss, D., Leliaert, A. K., Bhasin, M., de Boer, V. C. J., Laurent, G., Adams, A. C., Sundvall, M., Song, S. J., Ito, K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62129 · Cited by 269
Brown-fat-mediated tumour suppression by cold-altered global metabolism
Seki, T., Yang, Y., Sun, X., Lim, S., Xie, S., Guo, Z., Xiong, W., Kuroda, M., Sakaue, H., Hosaka, K., et al. (2022) · Nature · doi:10.1038/s41586-022-05030-3 · Cited by 263
MTOR inhibitors in cancer therapy
Xie, J., Wang, X., & Proud, C. G. (2016) · F1000Research · doi:10.12688/f1000research.9207.1 · Cited by 266
Emerging therapies in cancer metabolism
Xiao, Y., Yu, T.-J., Xu, Y., Ding, R., Wang, Y.-P., Jiang, Y.-Z., & Shao, Z.-M. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.006 · Cited by 256
Metallodrugs in cancer nanomedicine
Peña, Q., Wang, A., Zaremba, O., Shi, Y., Scheeren, H. W., Metselaar, J. M., Kiessling, F., Pallares, R. M., Wuttke, S., & Lammers, T. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00468a · Cited by 259
Pyruvate Kinase Isoform Expression Alters Nucleotide Synthesis to Impact Cell Proliferation
Lunt, S. Y., Muralidhar, V., Hosios, A. M., Israelsen, W. J., Gui, D. Y., Newhouse, L., Ogrodzinski, M., Hecht, V., Xu, K., Acevedo, P. N. M., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.10.027 · Cited by 257
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Kirtane, A. R., Kalscheuer, S. M., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 258
Caruso, P., Dunmore, B. J., Schlosser, K., Schoors, S., Dos Santos, C., Perez-Iratxeta, C., Lavoie, J. R., Zhang, H., Long, L., Flockton, A. R., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.028034 · Cited by 258
Succinate dehydrogenase (SDH)‐deficient neoplasia
Gill, A. J. (2018) · Histopathology · doi:10.1111/his.13277 · Cited by 256
“When we studied 309 unselected pituitary adenomas from our institution, SDH deficiency was found in only one case (0.3%)64 and, very unusually for SDH-deficient neoplasia, this case was not associated with germline mutation but rather with two somatic mutations in SDHA.”
BackgroundInfluentialMetabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer
Liu, S., Zhang, X., Wang, W., Li, X., Sun, X., Zhao, Y., Wang, Q., Li, Y., Hu, F., & Ren, H. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02165-x · Cited by 246
Invasion and metastasis in cancer: molecular insights and therapeutic targets
Li, Y., Liu, F., Cai, Q., Deng, L., Ouyang, Q., Zhang, X. H.-F., & Zheng, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02148-4 · Cited by 244
“224 Given the distinctive energy storage and consumption mechanisms of the brain, tumor cells are compelled to adapt to their metabolic microenvironment.”
Prigione, A., Rohwer, N., Hoffmann, S., Mlody, B., Drews, K., Bukowiecki, R., Blümlein, K., Wanker, E. E., Ralser, M., Cramer, T., et al. (2014) · Stem Cells · doi:10.1002/stem.1552 · Cited by 254
Li, L., & Li, W. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.004 · Cited by 254
Xu, D., Shao, F., Bian, X., Meng, Y., Liang, T., & Lu, Z. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.015 · Cited by 251
BNip3 Regulates Mitochondrial Function and Lipid Metabolism in the Liver
Glick, D., Zhang, W., Beaton, M., Marsboom, G., Gruber, M., Simon, M. C., Hart, J., Dorn, G. W., Brady, M. J., & Macleod, K. F. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00167-12 · Cited by 251
Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis
Ding, H., Jiang, L., Xu, J., Bai, F., Zhou, Y., Yuan, Q., Luo, J., Zen, K., & Yang, J. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00036.2017 · Cited by 250
The mitochondrial voltage-dependent anion channel 1 in tumor cells
Shoshan-Barmatz, V., Ben-Hail, D., Admoni, L., Krelin, Y., & Tripathi, S. S. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.040 · Cited by 247
Cárdenas, C., Müller, M., McNeal, A., Lovy, A., Jaňa, F., Bustos, G., Urra, F., Smith, N., Molgó, J., Diehl, J. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.030 · Cited by 247
Resveratrol: An overview of its anti-cancer mechanisms
Elshaer, M., Chen, Y., Wang, X. J., & Tang, X. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.06.028 · Cited by 245
“One of the first identified and most common metabolic change characteristics of cancer cells is altered glucose metabolism or what is called “Warburg effect” [111].”
BackgroundClassification of mitocans, anti-cancer drugs acting on mitochondria
Neuzil, J., Dong, L.-F., Rohlena, J., Truksa, J., & Ralph, S. J. (2013) · Mitochondrion · doi:10.1016/j.mito.2012.07.112 · Cited by 245
“It is also important to take into consideration the aberrant mitochondrial metabolism in malignant cells (Koppenol et al., 2011; Ward and Thompson,).”
BackgroundKalyanaraman, B. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.018 · Cited by 246
Alfarouk, K. O., Verduzco, D., Rauch, C., Muddathir, A. K., Bashir, A. H. H., Elhassan, G. O., Ibrahim, M. E., Orozco, J. D. P., Cardone, R. A., Reshkin, S. J., et al. (2014) · Oncoscience · doi:10.18632/oncoscience.109 · Cited by 245
The Warburg effect: Insights from the past decade
Upadhyay, M., Samal, J., Kandpal, M., Singh, O. V., & Vivekanandan, P. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.003 · Cited by 243
“Secondly, with the availability of new molecular techniques majority of cancer biologists shifted their focus toward investigating the role of genetic aberrations in cancer (Koppenol et al., 2011; Ward & Thompson, 2012).”
BackgroundMuscle dysfunction in cancer patients
Christensen, J. F., Jones, L. W., Andersen, J. L., Daugaard, G., Rorth, M., & Hojman, P. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt551 · Cited by 242
Kaji, K., Nishimura, N., Seki, K., Sato, S., Saikawa, S., Nakanishi, K., Furukawa, M., Kawaratani, H., Kitade, M., Moriya, K., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31193 · Cited by 241
Metabolic reprogramming in triple-negative breast cancer
Sun, X., Wang, M., Wang, M., Yu, X., Guo, J., Sun, T., Li, X., Yao, L., Dong, H., & Xu, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00428 · Cited by 243
DNA Damage, Repair, and Cancer Metabolism
Turgeon, M.-O., Perry, N. J. S., & Poulogiannis, G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00015 · Cited by 241
Obesity, DNA Damage, and Development of Obesity-Related Diseases
Włodarczyk, M., & Nowicka, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051146 · Cited by 242
Targeting cancer stem cells to suppress acquired chemotherapy resistance
Vidal, S. J., Rodriguez-Bravo, V, Galsky, M., Cordon-Cardo, C., & Domingo-Domenech, J. (2014) · Oncogene · doi:10.1038/onc.2013.411 · Cited by 242
Lucarelli, G., Galleggiante, V., Rutigliano, M., Sanguedolce, F., Cagiano, S., Bufo, P., Lastilla, G., Maiorano, E., Ribatti, D., Giglio, A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3823 · Cited by 239
“the shift to aerobic glycolysis with lactate production), alternative glucose metabolic pathways can be activated in order to generate the building blocks required for cancer cell growth [11-13].”
BackgroundThe Warburg effect: a signature of mitochondrial overload
Wang, Y., & Patti, G. J. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.03.013 · Cited by 235
Spectrum of somatic mitochondrial mutations in five cancers
Larman, T. C., DePalma, S. R., Hadjipanayis, A. G., The Cancer Genome Atlas Research Network, Protopopov, A., Zhang, J., Gabriel, S. B., Chin, L., Seidman, C. E., Kucherlapati, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211502109 · Cited by 240
PKM2 Regulates Chromosome Segregation and Mitosis Progression of Tumor Cells
Jiang, Y., Li, X., Yang, W., Hawke, D. H., Zheng, Y., Xia, Y., Aldape, K., Wei, C., Guo, F., Chen, Y., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.11.001 · Cited by 237
Seo, J., Jeong, D.-W., Park, J.-W., Lee, K.-W., Fukuda, J., & Chun, Y.-S. (2020) · Communications Biology · doi:10.1038/s42003-020-01367-5 · Cited by 237
Kalyanaraman, B., Cheng, G., Hardy, M., Ouari, O., Lopez, M., Joseph, J., Zielonka, J., & Dwinell, M. B. (2018) · Redox Biology · doi:10.1016/j.redox.2017.09.020 · Cited by 234
Glucose & oxygen exhausting liposomes for combined cancer starvation and hypoxia-activated therapy
Zhang, R., Feng, L., Dong, Z., Wang, L., Liang, C., Chen, J., Ma, Q., Zhang, R., Chen, Q., Wang, Y., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.004 · Cited by 234
SOD1, more than just an antioxidant
Eleutherio, E. C. A., Silva Magalhães, R. S., de Araújo Brasil, A., Monteiro Neto, J. R., & de Holanda Paranhos, L. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108701 · Cited by 232
Moro-García, M. A., Mayo, J. C., Sainz, R. M., & Alonso-Arias, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00339 · Cited by 234
Zhao, L., Ji, G., Le, X., Wang, C., Xu, L., Feng, M., Zhang, Y., Yang, H., Xuan, Y., Yang, Y., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1615 · Cited by 232
The Warburg effect: Evolving interpretations of an established concept
Chen, X., Qian, Y., & Wu, S. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.027 · Cited by 229
The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance
Huang, X., Gan, G., Wang, X., Xu, T., & Xie, W. (2019) · Autophagy · doi:10.1080/15548627.2019.1580105 · Cited by 230
Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways
Sørensen, B. S., & Horsman, M. R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00562 · Cited by 229
Keller, K. E., Tan, I. S., & Lee, Y.-S. (2012) · Science · doi:10.1126/science.1224409 · Cited by 228
Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond
Deblois, G., & Giguère, V. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3396 · Cited by 226
Kon, S., Ishibashi, K., Katoh, H., Kitamoto, S., Shirai, T., Tanaka, S., Kajita, M., Ishikawa, S., Yamauchi, H., Yako, Y., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3509 · Cited by 226
Vazquez, A., Kamphorst, J. J., Markert, E. K., Schug, Z. T., Tardito, S., & Gottlieb, E. (2016) · Journal of Cell Science · doi:10.1242/jcs.181016 · Cited by 225
The role of tumor-associated macrophages in tumor immune evasion
Huang, R., Kang, T., & Chen, S. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05777-4 · Cited by 230
“One hallmark of cancer cell metabolism is the Warburg effect, whereby tumor cells exhibit inefficient glucose utilization even in the presence of ample oxygen, preferring glycolysis over oxidative phosphorylation (OXPHOS) for energy production (Koppenol et al. 2011; Pavlova et al. 2022).”
BackgroundRegulation of Tumor Progression by Programmed Necrosis
Lee, S. Y., Ju, M. K., Jeon, H. M., Jeong, E. K., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3537471 · Cited by 215
Mutant p53 in Cancer Progression and Targeted Therapies
Zhu, G., Pan, C., Bei, J.-X., Li, B., Liang, C., Xu, Y., & Fu, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.595187 · Cited by 218
Hu, D., Linders, A., Yamak, A., Correia, C., Kijlstra, J. D., Garakani, A., Xiao, L., Milan, D. J., van der Meer, P., Serra, M., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.313249 · Cited by 219
Metadata
- Authors
- Koppenol, W. H., Bounds, P. L., & Dang, C. V.
- Affiliations
- ETH Zurich (CH)
- Johns Hopkins University (US)
- Corresponding author
- Koppenol, Willem H.
- Dang, Chi V.
- Venue
- Nature Reviews Cancer
- Published
- 2011-04-14
- Volume
- 11
- Issue
- 5
- Pages
- 325-337
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1998166655
- Cited by
- 3,427
- References
- 122
- Citations by year
- 2026: 204 · 2025: 296 · 2024: 316 · 2023: 321 · 2022: 300 · 2021: 287 · 2020: 260 · 2019: 225 · 2018: 176 · 2017: 183 · 2016: 170 · 2015: 175 · 2014: 177 · 2013: 143 · 2012: 152
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Update notices
- erratum (2011-07-14)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Association for Cancer Research
- Branco Weiss Fellowship – Society in Science
- Eidgenössische Technische Hochschule Zürich
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- Otto Warburg, Warburg effect, cancer metabolism, aerobic glycolysis, mitochondrial respiration, tumor hypoxia, photosynthesis, respiration, mitochondrial DNA, oncogenes, tumour suppressor, cancer therapy
- MeSH terms
- Germany, Glycolysis, Humans, Neoplasms, Cell Respiration, History, 20th Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.